Childhood ovarian cancer
Other Names for this Disease
- Ovarian carcinoma, childhood
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
On this page
(AstraZeneca Pharmaceuticals LP)
The FDA has approved this product to be used in this manner.
|Use of as monotherapy for patients with deleterious or suspected deleterious germline BRCA mutated (as detected by an FDA-approved test) advanced ovarian cancer who have been treated with three or more prior lines of chemotherapy|
|More Information about this product||Drug Information Portal|